Wearable Technology Insights
Aug 4, 2026

How CGMs are Riding the GLP-1 Wave to Transform Metabolic Health
The healthcare landscape is undergoing its most seismic shift in a generation. The catalyst is the explosive rise of GLP-1 receptor agonists like semaglutide and tirzepatide. Originally developed for type 2 diabetes, these medications have transformed into global blockbusters for weight management and metabolic health.








